Securities code: Aoyuan Beauty Valley Technology Co.Ltd(000615) securities abbreviation: Aoyuan Beauty Valley Technology Co.Ltd(000615) Announcement No.: 2022026 Aoyuan Beauty Valley Technology Co.Ltd(000615) 2021 annual report summary
1、 Important note: the summary of this annual report comes from the full text of the annual report. In order to fully understand the company’s operating results, financial status and future development plan, investors should carefully read the full text of the annual report in the media designated by the CSRC. All directors attended the meeting of the board of directors to review the annual report in person. The non-standard audit opinion prompt √ applicable □ not applicable. China audit Zhonghuan Certified Public Accountants (special general partnership) issued an unqualified audit report with emphasized items for the company. The board of directors and the board of supervisors of the company have made detailed explanations on relevant matters, which should be read by investors. The profit distribution plan of common stock or the plan of converting accumulation fund into share capital in the reporting period reviewed by the board of directors □ applicable √ not applicable. The company plans not to distribute cash dividends, bonus shares or convert accumulation fund into share capital. Preferred stock profit distribution plan for the reporting period adopted by the board of directors □ applicable √ not applicable II. Basic information of the company 1. Company profile
Stock abbreviation Aoyuan Beauty Valley Technology Co.Ltd(000615) Stock Code: Aoyuan Beauty Valley Technology Co.Ltd(000615)
Shenzhen Stock Exchange
Contact person and contact information secretary of the board of directors securities affairs representative
Name: Zhang Jianwei
Office address: Olympic Park, No. 48, Wanhui 1st Road, Panyu District, Guangzhou, Guangdong
13A floor, group building
Fax 02084506752
Tel: 02084506752
E-mail [email protected].
2. Introduction to main business or products during the reporting period
Main business conditions of the company during the reporting period:
1. Real estate: Business Optimization and effective stripping
In the first half of 2021, the company accelerated the project development and construction by paying close attention to the operation of the real estate sector, so as to ensure that all progress nodes comply with the development plan and deliver the building on schedule, so as to improve customer satisfaction; At the same time, the company actively realizes cost reduction and efficiency increase by optimizing product design, project scheme, personnel structure, cost strategy and other key measures; Benefit and efficiency are integrated together to consolidate the real estate performance in the first half of the year. In the second half of 2021, focusing on the business layout focusing on medical beauty, the company optimized the asset structure, realized the stripping of the real estate business through the sale of major assets, and further made progress to the development strategy of the material supplier, service supplier and technology supplier of the beauty and health industry.
2. Medical beauty materials: create a new benchmark for medical beauty materials and help the company transform
During the reporting period, the 40000 ton green fiber project in phase I of the 100000 ton lessel fiber project invested by the company was successfully put into operation, which achieved a new industry record of 100% excellent product rate of the full-automatic production line of lessel fiber, became a new benchmark of lessel industry 4.0, and effectively promoted the intelligent manufacturing process of lessel fiber industry and the high-quality development of China’s solvent method new cellulose fiber production technology. In the first project construction exchange meeting in 2021 in Xiangyang City, Hubei Province, the project was evaluated and scored by relevant departments of Xiangyang City and Fancheng district government, and won the first place in Xiangyang City. At present, as the third generation of bio based regenerated cellulose fiber, lessel products are mainly used in high-end consumption and manufacturing fields, especially for high-end medical beauty facial mask film cloth materials. The lessel series products produced by the company have successfully passed the test and certification of Annex VI of Oeko-Tex Association Standard 100 high-grade and strict standard class I (baby skin contact), and have been authorized to hang Oeko-Tex Standard 100 label on the product packaging. With the strength of the products, it has laid a solid technical foundation for the medical and American substrate business.
At the same time, Hubei Jinhuan green fiber has actively overcome the difficulties of the epidemic and taken multiple measures to continuously improve the quality of medical and American base material green fiber products. At present, it has become a supplier of leading cosmetics OEM enterprises. At the same time, it has made efforts to explore the Chinese sales market and cultivate high-end and core customers. Guided by quality, accelerate the development of foreign trade business and successfully enter the international market in early 2022.
During the reporting period, Hubei Jinhuan, a wholly-owned subsidiary, reached strategic cooperation with Shaoxing spring natural cellulose film Co., Ltd., which will not only transform, upgrade, improve the quality and speed of the traditional “cellophane” production line, but also invest in the construction of high-end medical and American drug tube grade cellulose film production line to improve its competitiveness in the field of medical and American drug tube grade cellulose film and environmental protection packaging tape; During the reporting period, Hubei Jinhuan won the “Hubei enterprise technology center” for the fifth time. In the next step, the company will focus on the industrial chain advantages of medical beauty base fiber and medical beauty drug tube grade cellulose film, strive to become a leading enterprise in China’s medical management industry and promote the transformation of the company’s medical beauty material supplier.
3. Medical beauty service: acquire high-quality medical beauty service targets and cut into the middle reaches of the medical beauty market; Put light on medical beauty and build a new model
The company focused on the medical beauty service end. In the first half of 2021, through the successful merger and acquisition of Hangzhou liantianmei medical beauty hospital and Hangzhou Victoria medical beauty hospital (5a medical beauty hospital, collectively referred to as “liantianmei hospital”), the company quickly entered the medical beauty industry chain. The company carried out effective post acquisition integration of its operations, assets and personnel, maintaining the continuous and stable operation of liantianmei hospital. When the epidemic prevention and control allows, Continue to implement measures such as optimizing doctor incentives, building brand image and steadily expanding channel sales, strengthen management and improve market competitiveness. The overall performance of liantianmei hospital increased steadily year-on-year in 2021, bringing positive contributions to the company.
At present, liantianmei hospital under the company has a sensitive grasp of medical technology trend and market information, and the management mode is relatively mature. Through resource integration, standardized internal control and fine management, it will provide strong support for the expansion of medical service market. The company has accumulated experience in various elements of post investment management, trained the medical beauty service end team and laid the foundation for the subsequent layout of the medical beauty service end. At the same time, the company will continue to promote the acquisition, integration and improvement of medical beauty service institutions, and set up medical beauty subdivided vertical market specialized stores with brand effect, so as to form a chain brand of medical beauty service end and improve the market competitiveness and brand influence.
In order to create the business temsector of “light medical beauty” of the company and enrich the medical beauty industry ecology of the company, in the second half of 2021, the company acquired Guangdong Aurora Health Management Consulting Co., Ltd. (hereinafter referred to as “Aurora”), two medical beauty institutions under Aurora, which can provide cost-effective and customized medical beauty services, covering from basic skin care projects of life beauty to high-end photoelectric anti-aging, injection filling and wrinkle removal projects, It has broad market space and rich customer groups.
At present, the company has improved the internal management and operation of Aurora’s medical beauty clinic, carried out store upgrading, service upgrading and other work, and grasped the diversified needs of customers for medical beauty services by actively improving the operation ability of “light medical beauty” and keeping up with market changes.
The company’s medical beauty business will be deeply cultivated in the Yangtze River Delta and Dawan district to build a “1 + n” model. “1” is a 5A level medical beauty hospital represented by liantianmei; “N” is a light medical beauty chain brand represented by Aurora.
4. Development of high-end medical products based on beauty technology
In July, 2021, the company successfully launched three new medical beauty products: fullerene cold compress (Liaoda Xibei No. 20200042), collagen polypeptide repair freeze-dried compound essence (Yuezhuang 20160235) and nano drug loaded cold compress, and spared no effort to create a product matrix of “makeup”, “machinery” and “medicine”.
5. Agency business of medical and American products: cooperate with various parties to expand upstream resources
In order to enrich the company’s medical and beauty industry ecology, enhance the popularity of the medical and beauty industry and help the company continue to expand to the upstream of medical and beauty, the company joined hands with partners such as sanuoxiu, KD medical, Yuantai and scientific doctors to conduct in-depth cooperation on the market promotion, application and product update of medical and beauty products, laser RF instruments and photoelectric beauty equipment. During the reporting period, the company cooperated with beautiful mother, a leader in China’s postpartum recovery industry, and Sano show, a global laser giant, to carry out exclusive agency of monalisatouch Monalisa Group Co.Ltd(002918) kiss private laser and other products; Signed a contract with won Tech (Yuantai), a leading brand in the field of optoelectronic medical equipment, and obtained the exclusive agency right of relevant products in China. The company expands industrial resources in the field of optoelectronic medical beauty, is committed to promoting the legalization of optoelectronic equipment and the standardization of health and beauty services, and continues to build the ecological strategic layout of medical beauty. 3. Main accounting data and financial indicators (1) whether the company needs to retroactively adjust or restate the accounting data of previous years in recent three years □ yes √ no
Unit: Yuan
Year end 2021 year end 2020 year end increase or decrease over the previous year year end 2019 year end
Total assets 432116584801945317403962 – 54.29% 1020820570052
Net assets attributable to shareholders of listed companies 146574889738171388819485 – 14.48% 183374572674
20212020 year-on-year increase or decrease 2019
Operating income 153867109998198734410608 – 22.58% 3150404442430
Net profit attributable to shareholders of listed company -25337226849 -13474941330 -88.03% 1208969230
Deductions attributable to shareholders of listed companies are not subject to -67149997770 -20104066781 -234 01% – 12067344375 net profit of recurring profit and loss
Net cash flow from operating activities -11425763701 -382582,581.94 70.14% 704840,860.57
Basic earnings per share (yuan / share) -0.32 -0.17 -88.24% 0.02
Diluted earnings per share (yuan / share) -0.32 -0.17 -88.24% 0.02
Weighted average return on net assets – 15.55% – 7.59% – 7.96% 0.64%
(2) Quarterly main accounting data
Unit: Yuan
First quarter second quarter third quarter fourth quarter
Operating income 6069995929455976686004275391726789651292022
Net profit attributable to shareholders of listed company 2990435195202248383016082719929 -46432865803
Net profit attributable to shareholders of listed companies after deducting non recurring profits and losses of 2756501931, 1981576310 -14610522870 -57277553141
Net cash flow from operating activities -12124787872 -768206271719306 Jiangsu Seagull Cooling Tower Co.Ltd(603269) -10925516381
Whether the above financial indicators or their total amount are significantly different from the financial indicators related to the quarterly report and semi annual report disclosed by the company □ yes √ No 4
